154 related articles for article (PubMed ID: 33632468)
1. Yeast-based high-throughput screens for discovery of kinase inhibitors for neglected diseases.
Tavella TA; Cassiano GC; Costa FTM; Sunnerhagen P; Bilsland E
Adv Protein Chem Struct Biol; 2021; 124():275-309. PubMed ID: 33632468
[TBL] [Abstract][Full Text] [Related]
2. Chemogenomics and bioinformatics approaches for prioritizing kinases as drug targets for neglected tropical diseases.
Borba JVVB; Silva AC; Lima MNN; Mendonca SS; Furnham N; Costa FTM; Andrade CH
Adv Protein Chem Struct Biol; 2021; 124():187-223. PubMed ID: 33632465
[TBL] [Abstract][Full Text] [Related]
3. The utility of yeast as a tool for cell-based, target-directed high-throughput screening.
Norcliffe JL; Alvarez-Ruiz E; Martin-Plaza JJ; Steel PG; Denny PW
Parasitology; 2014 Jan; 141(1):8-16. PubMed ID: 23611102
[TBL] [Abstract][Full Text] [Related]
4. Yeast as a potential vehicle for neglected tropical disease drug discovery.
Denny PW; Steel PG
J Biomol Screen; 2015 Jan; 20(1):56-63. PubMed ID: 25121554
[TBL] [Abstract][Full Text] [Related]
5. High Throughput and Computational Repurposing for Neglected Diseases.
Hernandez HW; Soeung M; Zorn KM; Ashoura N; Mottin M; Andrade CH; Caffrey CR; de Siqueira-Neto JL; Ekins S
Pharm Res; 2018 Dec; 36(2):27. PubMed ID: 30560386
[TBL] [Abstract][Full Text] [Related]
6. Drug discovery for neglected tropical diseases at the Sandler Center.
Robertson SA; Renslo AR
Future Med Chem; 2011 Aug; 3(10):1279-88. PubMed ID: 21859302
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases.
Dichiara M; Marrazzo A; Prezzavento O; Collina S; Rescifina A; Amata E
ChemMedChem; 2017 Aug; 12(16):1235-1253. PubMed ID: 28590590
[TBL] [Abstract][Full Text] [Related]
8. Yeast-Based High-Throughput Screens to Identify Novel Compounds Active against Brugia malayi.
Bilsland E; Bean DM; Devaney E; Oliver SG
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004401. PubMed ID: 26812604
[TBL] [Abstract][Full Text] [Related]
9. Modern Approaches for the Discovery of Anti-Infectious Drugs for the Treatment of Neglected Diseases.
Bellera CL; Sbaraglini ML; Talevi A
Curr Top Med Chem; 2018; 18(5):369-381. PubMed ID: 29741140
[TBL] [Abstract][Full Text] [Related]
10. In Silico Chemogenomics Drug Repositioning Strategies for Neglected Tropical Diseases.
Andrade CH; Neves BJ; Melo-Filho CC; Rodrigues J; Silva DC; Braga RC; Cravo PVL
Curr Med Chem; 2019; 26(23):4355-4379. PubMed ID: 29521204
[TBL] [Abstract][Full Text] [Related]
11. Integrated dataset of screening hits against multiple neglected disease pathogens.
Nwaka S; Besson D; Ramirez B; Maes L; Matheeussen A; Bickle Q; Mansour NR; Yousif F; Townson S; Gokool S; Cho-Ngwa F; Samje M; Misra-Bhattacharya S; Murthy PK; Fakorede F; Paris JM; Yeates C; Ridley R; Van Voorhis WC; Geary T
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1412. PubMed ID: 22247786
[TBL] [Abstract][Full Text] [Related]
12. A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases.
Berenstein AJ; Magariños MP; Chernomoretz A; Agüero F
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004300. PubMed ID: 26735851
[TBL] [Abstract][Full Text] [Related]
13. Fragment-based screening in tandem with phenotypic screening provides novel antiparasitic hits.
Blaazer AR; Orrling KM; Shanmugham A; Jansen C; Maes L; Edink E; Sterk GJ; Siderius M; England P; Bailey D; de Esch IJ; Leurs R
J Biomol Screen; 2015 Jan; 20(1):131-40. PubMed ID: 25231971
[TBL] [Abstract][Full Text] [Related]
14. Fragment-based approaches to the discovery of kinase inhibitors.
Mortenson PN; Berdini V; O'Reilly M
Methods Enzymol; 2014; 548():69-92. PubMed ID: 25399642
[TBL] [Abstract][Full Text] [Related]
15. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.
Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH
J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase profiling assays: a technology review.
Wang Y; Ma H
Drug Discov Today Technol; 2015 Nov; 18():1-8. PubMed ID: 26723886
[TBL] [Abstract][Full Text] [Related]
17. Yeast-based systems for tropical disease drug discovery.
Balaña-Fouce R; Reguera RM
Expert Opin Drug Discov; 2016; 11(5):429-32. PubMed ID: 26931823
[No Abstract] [Full Text] [Related]
18. Significance of Lipolytic Enzymes in Pathogenesis and Treatment of Neglected Diseases.
Chakravorty D; Patra S
Curr Protein Pept Sci; 2016; 17(3):228-42. PubMed ID: 26427383
[TBL] [Abstract][Full Text] [Related]
19. In silico repositioning of approved drugs for rare and neglected diseases.
Ekins S; Williams AJ; Krasowski MD; Freundlich JS
Drug Discov Today; 2011 Apr; 16(7-8):298-310. PubMed ID: 21376136
[TBL] [Abstract][Full Text] [Related]
20. UCSF Small Molecule Discovery Center: innovation, collaboration and chemical biology in the Bay Area.
Arkin MR; Ang KK; Chen S; Davies J; Merron C; Tang Y; Wilson CG; Renslo AR
Comb Chem High Throughput Screen; 2014 May; 17(4):333-42. PubMed ID: 24661212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
